Similarly, STIM1/ORAI1 overexpression in multiple myeloma or upregulation of ORAI1 in esophageal squamous cell carcinoma is associated with poorer progression-free survival [257,269,284]. The gene discussed is ORAI1; the disease is plasma cell myeloma.